Advertisement

Topics

Latest Clostridium difficile (CDI) NewsRSS

03:19 EDT 23rd September 2018 | BioPortfolio

PROSCRASTINATION : Comment le cerveau diffère

Nous différons tous dans notre capacité à initier des mécanismes de contrôle de soi et des émotions. Bien que les différences interindividuelles dans le contrôle des actions apportent une contribution majeure à notre vie quotidienne, leur fondation neurale reste largement inconnue. « La procrastination est un voleur de temps », écrivent ici ces chercheurs de l’Université de [̷...

Chambersburg Hospital Sets New Standard for Environmental Cleanliness; Decreases C.diff Infection Rates with Germ-Zapping Robots

Hospital Earns “Visionary” Status in Recognition of Program Success Chambersburg Hospital received the Healthgrades Distinguished Hospital Award for Clinical Excellence™ (2017 and 2018) while also being named one of Healthgrades America’s 100 Best Hospitals™ for Coronary Intervention, Orthopedic Surgery, Pulmonary Care, and Critical Care in 2...

Thinking C. diff ? Check the Diff(erential).

Absence of eosinophils was associated with double the odds of mortality and predicted severe disease.

Germ-Zapping Robots Enhance Infection Prevention; Riverside Medical Center Reports Reduction in Infections after Adding Pulsed Xenon UV Disinfection to Cleaning Protocols

Hospital Earns “Visionary” Status in Recognition of Program Success As hospitals around the world look for new and innovative ways to battle deadly pathogens and kill multi-drug resistant organisms that can endanger patients and hospital employees, Riverside Medical Center invested in state-of-the-art

Oragenics, Inc. to Present Data from Its Lantibiotics Program at the Boulder Peptide Symposium Monday, September 24, 2018

Oragenics, Inc. (NYSE American:OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), today announced that Dr. Martin Handfield, the company’s senior vice president of discovery research will present data on its lantibiotics program for the treatment of serious and prevalent inf...

Lewis County General Hospital Reduces Infection Rates with Germ-Zapping Robot; LightStrike Disinfection System Pays for Itself in Less Than 1 Year

Lewis County General Hospital is one of the cleanest hospitals in upstate New York. Just over a year ago, they began using Hector, a 4-foot tall LightStrike™ Germ-Zapping Robot™, to disinfect

Merck’s ZERBAXA® (ceftolozane and tazobactam) Met Primary Endpoints of Non-Inferiority Compared to Meropenem in Pivotal Phase 3 Study of Adult Patients with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia

Company Plans to Submit Supplemental New Drug Applications in the US and EU Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the pivotal Phase 3 clinical study evaluating the company’s antibiotic ZERBAXA® (ceftolozane and tazobactam) at an investigational dose for the treatment of adult ...

LightStrike Germ-Zapping Robots Help Hunterdon Medical Center Reduce Superbug Infection Rates by 76%

Hospital Earns “Visionary” Status in Recognition of Program Success As germs and bacteria become increasingly resistant to cleaning chemicals and antibiotics, Hunterdon Medical Center recently deployed Xenex LightStrike™ Germ-Zapping Robots™ that use

Compass Memorial Healthcare Takes Infection Control to a New Level

Compass Memorial Healthcare recently announced that it is the first and only Critical Access Hospital (CAH) in Iowa to deploy a Xenex LightStrike™ Germ-Zapping Robot™ as part of its daily infe

Germ-Zapping Robots Enhance Infection Prevention; Rush Foundation Hospital Reports Fewer Infections after Adding LightStrike Pulsed Xenon UV Disinfection as Environmental Standard of Care

Patient safety is a top priority at Rush Foundation Hospital, which was the first hospital in East Mississippi and West Alabama to deploy Xenex LightStrike™ Germ-Zapping Robots™ to enhance environmental cleanliness by disinfecting and destroying hard-to-kill germs, bacteria and superbugs in hard-to-clean places. The hospital announced today that ...

Sequella Inc Medical Equipment Deals and Alliances Profile [Report Updated: 12062018] Prices from USD $250

SummarySequella Inc Sequella is a clinicalstage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company's pipeline products comprise SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid antibiotic susceptibility test, BSMART. Sequella develops antibodies for infections such as mycobacterium tuberculosis, helicobacter pylori, clost...

Seres Therapeutics Strengthens Board of Directors with Appointment of Meryl Zausner, Experienced Biopharmaceutical Financial Leader

Seres Therapeutics, Inc. (Nasdaq:MCRB) today announced the appointment of Meryl Zausner, a seasoned biopharmaceutical executive, to its Board of Directors. Ms. Zausner brings decades of financial and operational leadership experience in the pharmaceutical industry. “Meryl Zausner is a highly accomplished financial and strategic leader, an...

Synthetic Biologics Inc SYN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 20062018] Prices from USD $250

SummarySynthetic Biologics Inc Synthetic Biologics, formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company's pipeline products include SYN004 and SYN010. Its SYN010 is a proprietary, modifiedrelease formulation which is intended to treat rritable bowel syndrome with constipation. Synthetic Biologics' SYN004 is an oral prophyl...

Kenall’s Indigo-Clean® and SenScape™ -- Winners of 2018 Product Innovation Awards

The Indigo-Clean MDLIC6 downlight and the SenScape™ luminaire both won Product Innovation Awards (PIA ’18) from Architectural SSL Magazine. KENOSHA, Wis. (PRWEB) August 29, 2018 In an industry crowded with newcomers, Kenall products still excel. It was announced this month that the Indigo-Clean MDLIC6 downlight and the SenScape™ luminaire both won Product Innovation Awards (PIA ’18) from...

Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings

Antimicrobial stewardship programs (ASPs) have been shown to reduce inappropriate antimicrobial use and its consequences. However, these programs lack legislative requirements in many places and it can be diff...

Appili Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryAppili Therapeutics Inc Appili Therapeutics is a biopharmaceutical company developing and commercializing antiinfective drugs for the treatment of infectious diseases and drugresistant pathogens. Its pipeline products include ATI1501, an oral suspension antibiotic liquid reformulation paired with metronidazole used for treating parasitic and anaerobic bacterial infections, including Clostri...

St. Bernard Parish Hospital Introduces Germ-Fighting Robot to Enhance Patient Safety

Community invited to submit name ideas for innovative robot St. Bernard Parish Hospital (SBPH) is enhancing patient safety and reducing the risk of healthcare-associated infections with a Xenex

BIOLOGIE SYNTHÉTIQUE : Des plantes phytocapteurs de mesures de santé ?

L'incorporation à la maison de plantes « mouchardes » ou espionnes capables de donner l’alarme -ou les niveaux- de différentes mesures de santé est à l'horizon, avec ce développement de l’Université de l'Institut d'Agriculture du Tennessee, présenté dans la revue Science. Des plantes qui grâce aux progrès de cette nouvelle discipline, la biologie synthétique,...

ANTIMICROBIAL STEWARDSHIP PROGRAMS IN DIALYSIS CLINICS REDUCE INFECTIONS, COSTS

On a national level, implementation of antimicrobial stewardships in outpatient dialysis facilities would result in 2182 fewer infections caused by multidrug-resistant organisms and Clostridium difficile (a 4.8% reduction) per year. It would also lead to 629 fewer infection-related deaths (a 4.6% reduction) and a cost savings of $99,804,603 (a 4.7% reduction) per year.

Assembly Biosciences Inc ASMB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryAssembly Biosciences Inc Assembly, formerly Ventrus Biosciences Inc is a biotechnology company that discover, develops and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as chronic hepatitis B virus HBV and microbiotic therapies for Clostridium difficile C. difficile infections CDI. It also develops Gemicel platform tech...

ANESTHÉSIE : A l’âge avancé, elle brouille durablement la pensée

Plusieurs études ont déjà suggéré un impact de l’anesthésie sur la mémoire, avec des effets différents chez les adultes et les enfants. Cette étude de la Mayo Clinic associe, chez les adultes plus âgés l’anesthésie à un déclin qui peut être durable de la mémoire et de la pensée. Des données présentées dans le British […]

The dogs were supposed to be experts at sniffing out C. diff. Then they smelled breakfast

A hospital trained dogs to try to detect the bacterium Clostridium difficile. But they weren't perfect — and they "found it hard to pass a toilet without drinking out of it."

Sequella Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11072018] Prices from USD $250

SummarySequella Inc Sequella is a clinicalstage pharma company that develops antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company's pipeline products comprise SQ109, Sutezolid, SQ641 and SQ609; and a novel rapid antibiotic susceptibility test, BSMART. Sequella develops antibodies for infections such as mycobacterium tuberculosis, helicobacter pylori, clost...

GÉNÉTIQUE et MODE de VIE : 2 jumeaux, l’un devient athlète, l’autre chauffeur routier

Intéressante comparaison des résultats de santé de 2 jumeaux aux modes de vie très différents, menée par cette équipe de la San Francisco State University. Certes, il ne s’agit que d’une analyse de cas et on ne saurait en généraliser ses conclusions. Cependant, les résultats de cette analyse, présentés dans l’European Journal of Applied Physiology […]

Trinity Guardion® Releases Informational Hospital Mattress Surface Video

Animated view of a germs life on a hospital mattress. BATESVILLE, Ind. (PRWEB) August 18, 2018 This short video is funny, but the subject – not so much. Trinity Guardion, provider of the Soteria™ Bed Barrier infection prevention products for hospital mattresses, has created a light hearted way to spread the message of soft surface contamination issues on hospital mattresses. In light of growi...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Clostridium difficile (CDI) market research data and corporate reports here